VNS Therapy AspireSR Generator Model 106. Indicated for use as an adjunctive therapy in reduci...
FDA Device Recall #Z-0659-2016 — Class II — December 18, 2015
Recall Summary
| Recall Number | Z-0659-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | December 18, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Cyberonics, Inc |
| Location | Houston, TX |
| Product Type | Devices |
| Quantity | 4,935 units |
Product Description
VNS Therapy AspireSR Generator Model 106. Indicated for use as an adjunctive therapy in reducing the frequency of seizures.
Reason for Recall
Recall being initiated in response to three reports of "Burst Watchdog Timeout" events occurring with the Model 106 AspireSR Generator, resulting in a device reset condition where stimulation output is disabled.
Distribution Pattern
Worldwide Distribution -- United States, Austria, Belgium, Croatia, Czech Republic, Finland, France, Germany, Iceland, Italy, Netherlands, Norway, Poland, Slovakia, Spain, Sweden, Switzerland, United Kingdom, Cyprus, Israel, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, and United Arab Emirates.
Lot / Code Information
All VNS Therapy AspireSR (Model 106) Generators; Device Identifier - (01)05425025750061
Other Recalls from Cyberonics, Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0555-2018 | Class II | VNS(R) Therapy Programmer, GMDN: 44077, Model ... | Dec 2, 2017 |
| Z-2255-2018 | Class II | VNS Therapy Programmer, Model 3000, v1.0 System | Nov 13, 2017 |
| Z-3019-2017 | Class II | VNS Therapy¿ AspireHC¿ Generator, VNS Therapy¿ ... | Jun 13, 2017 |
| Z-3020-2017 | Class II | VNS Therapy¿ AspireHC¿ Generator, VNS Therapy¿ ... | Jun 13, 2017 |
| Z-0645-2016 | Class II | Cyberonics Vagus Nerve Stimulator VNS Therapy A... | Nov 18, 2015 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.